Apex Biotech Ltd

Products&Service

Knowledge
Home > Knowledge > Content

About Silibinin(Silybin)

Source:Wikipedia      Date:Mar 25, 2016

 

Silibinin (INN), also known as silybin (both from Silybum, the generic name of the plant from which it is extracted), is the major active constituent of silymarin, a standardized extract of the milk thistle seeds, containing a mixture of flavonolignansconsisting of silibinin, isosilibinin, silicristin, silidianin and others. Silibinin itself is mixture of two diastereomers, silybin A and silybin B, in approximately equimolar ratio.

 

Pharmacology

 

Poor water solubility and bioavailability of silymarin led to the development of enhanced formulations. Silipide (trade nameSiliphos), a complex of silymarin and phosphatidylcholine (lecithin), is about 10 times more bioavailable than silymarin.[3] An earlier study had concluded Siliphos to have 4.6 fold higher bioavailability.[4] It has been also reported that silymarin inclusion complex with β-cyclodextrin is much more soluble than silymarin itself.[5] There have also been prepared glycosides of silybin, which show better water solubility and even stronger hepatoprotective effect.[6]

Silymarin, as other flavonoids, has been shown to inhibit P-glycoprotein-mediated cellular efflux.[7] The modulation of P-glycoprotein activity may result in altered absorption and bioavailability of drugs that are P-glycoprotein substrates. It has been reported that silymarin inhibits cytochrome P450 enzymes and an interaction with drugs primarily cleared by P450s cannot be excluded.[8]

Toxicity

A phase I clinical trial in humans with prostate cancer designed to study the effects of high dose silibinin found 13 grams daily to be well tolerated in patients with advanced prostate cancer with asymptomatic liver toxicity (hyperbilirubinemia and elevation of alanine aminotransferase) being the most commonly seen adverse event.[9]

Silymarin is also devoid of embryotoxic potential in animal models.[10][11]

Medical uses

Silibinin is available as drug (Legalon® SIL (Madaus) (D, CH, A) and Silimarit® (Bionorica), a Silymarin product) in some EU countries and used in the treatment of toxic liver damage (e.g. IV treatment in case of death cap poinsining); as adjunctive therapy in chronic hepatits and cirrhosis. See also Silybum_marianum#Medicinal_use

Potential medical uses

Silibinin is under investigation to see whether it may have a role in cancer treatment (eg due to its inhibition of STAT3 signalling).[12]

Silibinin also has a number of potential mechanisms that could benefit the skin. These include chemoprotective effects from environmental toxins, anti-inflammatory effects, protection from UV induced photocarcinogenesis, protection from sunburn, protection from UVB-induced epidermal hyperplasia, and DNA repair for UV induced DNA damage.[13]

Biotechnology

Silymarin can be produced in callus and cells suspensions of Silybum marianum and substituted pyrazinecarboxamides can be used as abiotic elicitors of flavolignan production.[14]

 

Feedback
Contact Us
Address: No.6 Zhangba 4th Rd., Xi’an Hi-Tech Zone, Xi'an 710077, China.
Tel: +86 (29) 8860 1330
Fax: +86(29) 8860 9131
E-mail:info@apex-bio.com
Copyright © Apex Biotech Ltd